US (NM): Federally-authorized cannabis grower's 22-acre greenhouse in progress

Bright Green Corporation, one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications, and affiliated export, today provided an update on the progress made on its world-class agricultural complex in Grants, New Mexico.

Since the company's direct listing on Nasdaq in May 2022, significant progress has been made on its development efforts as it prepares to grow, manufacture and market federally-compliant cannabis in one of the world's largest, most advanced agricultural ecosystems for medicinal plants.


Outside perimeter of the 22-acre facility that will be completed in August 2022 

Upgrades to existing facility
Bright Green is on pace to complete the renovation of its existing 22-acre facility this coming August. The company has completed the installation of medical-grade panels throughout the interior and exterior walls, and the greenhouse facility has been reglazed with special glass that transmits 98% light with a 20% haze, which is optimal light intensity based on the environmental conditions in Grants. A high-tech security solution is in the process of installation and inspections to ensure compliance with the company's standard operating procedures and all federal security requirements. Clean rooms and offices are expected to be delivered and installed in the coming weeks.

"We are excited to report on the immense progress we have made at our world-class agricultural facility since listing on Nasdaq on May 17, 2022," said Bright Green's Chairman of the Board, Terry Rafih. "These developments ensure we will meet the highest standard of U.S. Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA) security and diversion control at completion and enable us to begin growing high-quality, pharmaceutical-grade cannabis in Grants later this year."


Outside view of the agricultural facility that offers optimal light intensity to support the environmental conditions and facilitate growth in the greenhouse

High-tech cannabis production facility
Beyond the initial facility outlined above, the company is also focused on the construction of two additional greenhouses that are 57 acres each and will facilitate cannabis research, development, cultivation, and manufacturing operations. Construction on Phase 2 is expected to commence in 2023, subject to capital and normalization of supply chain issues. Bright Green plans to equip these additional facilities with cutting-edge technologies supplied by Dalsem Greenhouse Solutions. The implementation of these, and other renewable energy technologies, should allow the company to maintain a net-zero carbon footprint once operational.

Completing the facility and leveraging the cannabis manufacturing expertise of Bright Green's team, the unique climate of New Mexico, and its suitability for cannabis crops will enable the Company to meet the significant demand for its high-quality cannabis products that it anticipates from the U.S. and international markets.

Once fully built out, Bright Green anticipates its facilities will be capable of producing up to ~100,000 grams of resin per day with a concentration of a minimum of 85% useful cannabinoids for commercialization. The capacity of this facility should yield more than 850 million grams per year.


Entrance to Bright Green's agricultural complex in Grants, NM.  

DEA inspection
Bright Green construction projects are proceeding on schedule for the company's inspection by the DEA, now scheduled for later this summer. Following the DEA's authorization post-inspection, Bright Green will commence growing plants in its current 22-acre production facility and selling cannabis to DEA-registered pharmaceutical companies to produce medicinal cannabis or cannabis preparations. DEA registration will also enable the company to produce and sell cannabis for export internationally and to supply the growing cannabis clinical research market to those who hold a license comparable to a U.S. Schedule 1. The company's first harvest is expected this fall.

Techson IP
In early June 2022, Bright Green entered into a partnership agreement with Techson IP, a patent and intellectual property strategy consulting firm, to collaborate on the acquisition and future development of intellectual property (IP) across the cannabis industry. As Bright Green's broker, Techson will research, review and assess new IP available in the sector and being offered to Bright Green for acquisition or licensing. Techson will also provide research and consulting services as Bright Green ramps up its growing operations and brings its world-class research and development facilities online.

For more information:
Bright Green 
www.brightgreen.us 


Publication date:



Receive the daily newsletter in your email for free | Click here


Other news in this sector:


Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber